Ronald Fischer captured; biotech exec role confirmed

Former anesthesiologist Ronald L. Fischer, convicted in absentia of first‑degree sexual assault in Rhode Island, was taken into custody on July 16 2026 after authorities intercepted his 56‑foot sailing vessel The Silver Lining off the New Jersey–New York coast. The operation, coordinated by the Rhode Island Violent Fugitive Task Force, FBI, U.S. Marshals Service, Rhode Island State Police and the U.S. Coast Guard, ended a 21‑year manhunt that began when Fischer fled his 2005 trial.

Investigators searched Fischer’s residence and uncovered books on evading law‑enforcement and evidence that he had used an “onion router” for online anonymity. The search also confirmed that Fischer had been operating under the alias Richard Graydon, which was listed as chief medical officer for Los Angeles‑based biotech firm Immix Biopharma—a position he assumed in March 2026.

Authorities confirmed the interception occurred about an hour offshore from the New Jersey shoreline. The sailboat was boarded without incident and Fischer was handed over at a Coast Guard station on Staten Island before being transferred to state police for extradition to Rhode Island. Officials noted the breakthrough resulted from fresh intelligence gathered over a 48‑hour period, not a tip to America’s Most Wanted. The capture concludes the longest‑running fugitive hunt of its kind.